Top Tweets for #TNBCDX
Announcing a link between B-cell and T-cell immune infiltration and improved survival rates in #breastcancer survivors. These are integrated into #HER2DX and #TNBCDX, enhancing their role in guiding clinical decisions for HER2+ and TNBC.
More: https://t.co/eOG6ExVTv4

#TNBCDX at #SABCS24 too!!
@JavierCortesMD about optimizing the prognosis of patients with TNBC
#breastcancer

El nostre CSO i cofundador @prat_aleix parla a @SEGREcom sobre #TNBCDX i el càncer de mama triple negatiu, destacant la importància d’ajudes com la @BecaMartaS. Llegeix l’article aquí (en català):
https://t.co/BzIrgySpca
On this day, we reaffirm our commitment to advancing research, innovation, and #precisiononcology. Every breakthrough brings us closer to better outcomes for #patients. #PrecisionOncology #Innovation #BreastCancerAwarenessMonth #HER2DX #DNADX #TNBCDX
This week brings exciting news:
Just published in @Annals_Oncology! ⭐️
Introducing #TNBCDX – a genomic test that predicts outcomes for early-stage TNBC patients treated with neoadjuvant taxane-based therapy, with or without pembrolizumab. Read it here: https://t.co/eECsEXwQkD
📢Development and validation of #TNBCDX a new genomic biomarker for early-stage triple-negative breast cancer with an without pembrolizumab.
Published in @Annals_Oncology
https://t.co/ylFMtdatFx
@prat_aleix @VHIO @Laiapb @fara_bm @RevealGenomics
🎉 Celebrating 4 amazing years today! This milestone is just the beginning, thanks to our visionary leadership, committed team, and everyone who trusts us. We are dedicated to transforming cancer care to benefit patients. 🚀 #breastcancer #HER2DX #DNADX #TNBCDX

@DrLisaCarey highlights #TNBCDX and mentions #HER2DX: We're revolutionizing #precisiononcology in #breastcancer with these cutting-edge tools! Exciting advancements are here, benefiting patients and shaping the future. 🚀 #ESMO24 #ESMO2024

Conclusions from Dr. Miguel Martin's presentation on #TNBCDX, the test that will transform the treatment landscape for Triple-Negative #breastcancer
#precisiononcology #esmo24 #ESMO2024

#TNBCDX is making an impact at #ESMO24 💡 The first genomic test for early-stage triple-negative #breastcancer shows a strong association with pCR, DDFS, and OS. Dr. Miguel Martin is presenting now. #precisiononcology
More info: https://t.co/Vza5FoZqpC

Across two independent validation studies with 418 patients, the #TNBCDX® scores showed a strong association with pathological complete response (pCR), distant disease-free survival (DDFS), and overall survival (OS).
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.1M followers

Barack Obama 
@barackobama
119.3M followers

Donald J. Trump 
@realdonaldtrump
111.6M followers

Cristiano Ronaldo 
@cristiano
109.1M followers

Narendra Modi 
@narendramodi
106.9M followers

Rihanna 
@rihanna
97.3M followers

NASA 
@nasa
92.1M followers

Justin Bieber 
@justinbieber
90.6M followers

KATY PERRY 
@katyperry
86.9M followers

Taylor Swift 
@taylorswift13
80.7M followers

Lady Gaga 
@ladygaga
72.3M followers

Kim Kardashian 
@kimkardashian
69.4M followers

Virat Kohli 
@imvkohli
68.7M followers

YouTube 
@youtube
68.6M followers

Bill Gates 
@billgates
63.4M followers

The Ellen Show
@theellenshow
62.5M followers

CNN 
@cnn
61.9M followers

Neymar Jr 
@neymarjr
61.3M followers

X 
@x
60.9M followers

Selena Gomez 
@selenagomez
60M followers



